Article
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.
Proceedings of the National Academy of Sciences of the United States of America - 2 May 2006
Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm E B, Hotamisligil G S
Abstract excerpt
Obesity and the associated pathologies including dyslipidemia, insulin resistance, type 2 diabetes, and cardiovascular disease constitute a major threat to global human health. Yet, the genetic factors that differentially predispose individuals to this cluster of pathologies are unclear. The fatty acid-binding protein aP2 is a cytoplasmic lipid chaperon expressed in adipocytes and macrophages. Mice with aP2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
